Skip to Content
Merck

LC/MS Analysis of Conjugated Bile Acids on Ascentis® Express C18

LC/MS Analysis of Conjugated Bile Acids on Ascentis® Express C18 application for HPLC

Materials

analytical column

Product No.
Description
Pricing

Ascentis® Express C18, 2.7 μm HPLC Column

2.7 μm particle size, L × I.D. 5 cm × 4.6 mm

mobile phase component

Product No.
Description
Pricing

Ammonium acetate

LiChropur, eluent additive for LC-MS

standard

Product No.
Description
Pricing

Taurocholic acid sodium salt hydrate

≥95% (HPLC)

Sodium glycochenodeoxycholate

Sodium taurochenodeoxycholate

Sodium taurodeoxycholate hydrate

≥95% (HPLC)

Glycocholic acid hydrate

synthetic, ≥97% (HPLC)

CONDITIONS

column

Ascentis Express C18, 5 cm x 4.6 mm I.D., 2.7 μm particles (53826-U)

mobile phase

[A] 10 mM ammonium acetate, pH 4 with acetic acid; [B] acetonitrile

gradient

25 to 40% B in 10 min

flow rate

1.0 mL/min (postcolumn split to MS)

column temp.

35 °C

detector

MS, ESI(-), SIR

injection

5 μL

sample

10 mg/L each in mobile phase A

Description

Legal Information

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany